The historical rank and industry rank for China Pharma Holding's Gross Margin % or its related term are showing as below:
CPHI'
s Gross Margin % Range Over the Past 10 Years
Min: -6.1 Med: 12.81 Max: 20.67
Current: -4.01
During the past 13 years, the highestGross Margin % of China Pharma Holding was 20.67%. The lowest was -6.10%. And the median was 12.81%.
CPHI's Gross Margin % is ranked worse than 95.96% of 990
companies
in the Drug Manufacturers industry
Industry Median: 46.8
vs CPHI: -4.01
China Pharma Holding had a gross margin of -3.67% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for China Pharma Holding was 0.00% per year.
China Pharma Holding Gross Margin % Historical Data
The historical data trend for China Pharma Holding's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Pharma Holding's Gross Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding's Gross Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Gross Margin % distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
China Pharma Holding (OTCPK:CPHI) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
China Pharma Holding had a gross margin of -3.67% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
China Pharma Holding Gross Margin % Related Terms
Thank you for viewing the detailed overview of China Pharma Holding's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
China Pharma Holding (China Pharma Holding) Business Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CPHI has been successfully added to your 